Wiley Rein Scores WilmerHale FDA Policy Guru
Czaban told Law360 that he chose Wiley Rein because it is “a very sophisticated Washington-oriented firm” with a well-established history of taking on “cutting-edge FDA related work.”
Czaban’s practice emphasizes the interrelated legal, regulatory and policy issues stemming from competitive pressures within the pharmaceutical industry.
In addition to product development and promotional...
To view the full article, register now.